CM Life Sciences, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CMLF research report →
Companyi.cmlifesciencesspac.com
CM Life Sciences, Inc. intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. The company was founded in 2020 and is based in New York, New York.
- CEO
- Eli Decatur Casdin
- IPO
- 2020
- HQ
- New York City, NY, US
Price Chart
Valuation
- Market Cap
- $0
- P/E
- -4.37
- P/S
- 0.00
- P/B
- 1.34
- EV/EBITDA
- 0.47
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 69.56%
- Op Margin
- -14.91%
- Net Margin
- -17.58%
- ROE
- -27.50%
- ROIC
- -15.46%
Growth & Income
- Revenue
- $427.54M · 39.97%
- Net Income
- $-21,021,000 · 59.80%
- EPS
- $-0.73 · 62.37%
- Op Income
- $-13,077,000
- FCF YoY
- 141.96%
Performance & Tape
- 52W High
- $27.18
- 52W Low
- $9.66
- 50D MA
- $12.71
- 200D MA
- $14.38
- Beta
- 0.00
- Avg Volume
- 723.14K
Get TickerSpark's AI analysis on CMLF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jul 22, 21 | Casdin Eli | other | 10,993,750 |
| Jul 22, 21 | Casdin Eli | other | 6,736,669 |
| Jul 22, 21 | Casdin Eli | other | 5,000,000 |
| Jul 22, 21 | Casdin Eli | other | 10,993,750 |
| Sep 1, 20 | George Sean E | other | 0 |
| Sep 1, 20 | CMLS Holdings LLC | other | 9,987,500 |
| Sep 1, 20 | Leproust Emily M. | other | 25,000 |
Our CMLF Coverage
We haven't published any research on CMLF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate CMLF Report →